NCT00001758View on ClinicalTrials.gov

Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 1997

Study Completion Date

August 31, 2003

Conditions
HIV Infection
Interventions
DRUG

Abacavir

DRUG

Amprenavir

DRUG

Efavirenz

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001758 - Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz | Biotech Hunter | Biotech Hunter